Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Affect Reactivity and Regulation on Breast Cancer Treatment Decisions

NCT03050463 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT03050463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03050463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Affect Reactivity and Regulation on Breast Cancer Treatment Decisions
Lead sponsor
Stanford University
Phase
Observational
Overall status
Completed
Start date
August 31, 2016
Completion date
July 8, 2021
Enrollment
178 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subject, stage 0 breast cancer, stage ia breast cancer, stage ib breast cancer, stage iia breast cancer, stage iib breast cancer, stage iiia breast cancer, stage iiib breast cancer, stage iiic breast cancer